Risk and Safety of Probiotics
Open accessThe DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Abstract
Probiotics have been used safely for years. Safety outcomes are inconsistently reported in published clinical trials. In 2011, a report released by the Agency for Healthcare Research and Quality concluded that, although the existing probiotic clinical trials reveal no evidence of increased risk, "the current literature is not well equipped to answer questions on the safety of probiotics in intervention studies with confidence." Critics point out that the preponderance of evidence, including the long history of safe probiotic use as well as data from clinical trials, and animal and in vitro studies all support the assumption that probiotics are generally safe for most populations. Theoretical risks have been described in case reports, clinical trial results and experimental models, include systemic infections, deleterious metabolic activities, excessive immune stimulation in susceptible individuals, gene transfer and gastrointestinal side effects. More research is needed to properly describe the incidence and severity of adverse events related to probiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although probiotics are widely used and generally considered safe for healthy individuals, accumulating evidence indicates that their safety profile varies significantly depending on the strain, dose, host, and context, with rare but clinically significant adverse events reported in vulnerable populations.”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Vulnerable populations (newborns, immunocompromised individuals, and critically ill individuals) are at greater risk; therefore, assessing regulatory compliance requires a combination of biochemical and metabolomic studies, whole genome sequencing for virulence, antibiotic resistance genes and motility mapping [63,66,87].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, in the same year, Doron et al. (2015) conducted an analysis based solely on traditional literature review methods based on the results of 622 probiotic safety studies [63].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with established guidance, probiotic safety is linked to intended use, strain identity, and historical evidence of safe exposure, and is distinct from classical pathogenic risk assessment.20-22”
From Safety and efficacy concerns in Indian probiotics: Insights from whole-genome sequencing and in vitro assessment (2026) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The presence of such ARGs and VFs may have clinical relevance, particularly in immunocompromised individuals or those with disrupted gut barriers, where opportunities for opportunistic infection or horizontal gene transfer may be increased.22,29-35”
From Safety and efficacy concerns in Indian probiotics: Insights from whole-genome sequencing and in vitro assessment (2026) · cites this paper as [22]
Experimental — accuracy not yet measured
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial
Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., & Isolauri, E. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04259-8 · Cited by 2,432 · cited 1×
“Pregnant women [19–21] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii None”
BackgroundBesselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60207-x · Cited by 1,367
Probiotics in the management of atopic eczema
Isolauri, E., Arvola, T., SÜtas, Y., Moilanen, E., & Salminen, S. (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00943.x · Cited by 974 · cited 1×
“Infants [15–18] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii, Bb12, L reuteri One mechanical choking episode reported”
BackgroundProbiotics: A novel approach in the management of food allergy
Majamaa, H., & Isolauri, E. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70093-9 · Cited by 918 · cited 1×
“Infants [15–18] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii, Bb12, L reuteri One mechanical choking episode reported”
BackgroundProbiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg, J. Z., Ma, S. S., Saxton, J. D., Martzen, M. R., Vandvik, P. O., Thorlund, K., Guyatt, G. H., & Johnston, B. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub3 · Cited by 741
Lactobacillus Sepsis Associated With Probiotic Therapy
Land, M. H., Rouster-Stevens, K., Woods, C. R., Cannon, M. L., Cnota, J., & Shetty, A. K. (2005) · Pediatrics · doi:10.1542/peds.2004-2137 · Cited by 599 · cited 1×
“Nine cases of overt sepsis have been reported [57–63], asso-”
BackgroundKhalesi, S., Sun, J., Buys, N., & Jayasinghe, R. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03469 · Cited by 516
Rayes, N., Seehofer, D., Theruvath, T., Schiller, R. A., Langrehr, J. M., Jonas, S., Bengmark, S., & Neuhaus, P. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00649.x · Cited by 478 · cited 2×
“Immunocompromised [12–14] Pediacoccus pentosaceus, Leuconostoc mesenteroides, Lactobacillus paracasei subspecies paracasei F19, Lactobacillus plantarum, LGG, L.”
BackgroundRayes, N., Seehofer, D., Hansen, S., Boucsein, K., M??ller, A. R., Serke, S., Bengmark, S., & Neuhaus, P. (2002) · Transplantation · doi:10.1097/00007890-200207150-00021 · Cited by 476 · cited 2×
“Immunocompromised [12–14] Pediacoccus pentosaceus, Leuconostoc mesenteroides, Lactobacillus paracasei subspecies paracasei F19, Lactobacillus plantarum, LGG, L.”
Background
Research works printed but not linked: 3
- Kukkonen, 2008, Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial, Pediatrics, 122, 8, 10.1542/peds.2007-1192 · DOI · Paper page
- Trautmann, 2008, Fungemia due to Saccharomyces cerevisiae var. boulardii, Chemother J, 17, 57
- Lestin, 2003, Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities, Dtsch Med Wochenschr, 128, 2531
Cited by
Items 501–600 of 1,000
Nanomaterial‐assisted oncolytic bacteria in solid tumor diagnosis and therapeutics
Zeng, X., Chen, Q., & Chen, T. (2024) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10672 · Cited by 10
“88 Engineered bacteria maintain wild bacteria's kinetic activity and reduce toxicity.”
BackgroundShi, S., Li, X., Zhang, F., Jiang, Z., Wang, J., Zhao, L., Chen, J., Shu, X., Fang, B., Liu, P., et al. (2024) · Foods · doi:10.3390/foods13223618 · Cited by 10
“However, the administration of live microorganisms may not always be suitable because some subjects may experience gastrointestinal discomfort and even systemic infections due to probiotics intolerance [23].”
A Perspective on the Application of Pro-/Synbiotics in Clinical Practice
Wu, X., Chen, Y., & Huang, W. C. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00866 · Cited by 10
“Microbiologists have explained that the behavior of a microbe depends on several factors, we are ignoring the warnings (Sanders et al., 2010; Pirofski and Casadevall, 2012; Didari et al., 2014; Doron and Snydman, 2015).”
BackgroundProbióticos en diarrea aguda, asociada a antibióticos y nosocomial: evidencia en pediatría
Bustos, S., & Chamorro, J. F. V. (2018) · Revista Colombiana de Gastroenterología · doi:10.22516/25007440.230 · Cited by 10
Han, N., Liu, Y., Li, X., Du, J., Guo, L., & Liu, Y. F. (2024) · Journal of Periodontal Research · doi:10.1111/jre.13233 · Cited by 10
Abbas, M. O., Ahmed, H., Hamid, E. A., Padayachee, D., Abdulbadia, M. T., Khalid, S., Abuelhana, A., & Rasool, B. K. A. (2024) · Antibiotics · doi:10.3390/antibiotics13100967 · Cited by 10
Jastrząb, R., Tomecki, R., Jurkiewicz, A., Graczyk, D., Szczepankowska, A. K., Mytych, J., Wolman, D., & Siedlecki, P. S. (2024) · Microbial Cell Factories · doi:10.1186/s12934-024-02345-w · Cited by 10
Scauro, A., Rocchetti, M. T., Soccio, M., la Gatta, B., Liberatore, M. T., Simone, N. D., Spano, G., Fiocco, D., & Russo, P. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10538-x · Cited by 10
“The administration of postbiotics could be considered safer compared to probiotics, especially in vulnerable populations such as immunosuppressed, avoiding some potential adverse effects of live microbes [6, 7].”
Design of probiotic-nanozyme synergistic systems: A new bio-hybrid strategy for disease therapy
Dai, C., Liu, Y., Li, W., Gu, Q., Han, J., Ma, C., Liu, X., Ngai, T., Su, J., McClements, D. J., et al. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217228 · Cited by 10
Li, P., Wang, X., Wang, Y., Guo, J., & Yang, J. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102485 · Cited by 11
“Probiotics applied to patients with severe acute ulcerative colitis are also prone to causing dangerous infections [165].”
Modulating the gut microbiome-immune axis in shrimp: Use of probiotics to enhance disease resistance
Negi, A., & Chen, J.-Y. (2025) · Aquaculture · doi:10.1016/j.aquaculture.2025.743214 · Cited by 10
Chen, P., Hsu, H.-Y., Liao, Y.-C., Lee, C.-C., Hsieh, M.-H., Kuo, W.-S., Wu, L. S., & Wang, J. (2025) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap-211123-1733 · Cited by 10
Wang, J., Xu, Q., Lu, C., Cao, J., Zhuang, L., Li, Y., Li, Z., Song, Y., Zhou, S., Zhong, F., et al. (2025) · Food & Function · doi:10.1039/d4fo03094j · Cited by 10
Clinical trial of oral administration of Bifidobacterium longum in dogs with atopic dermatitis
Lee, K.-I., Yun, T., Ham, J.-S., Lee, W.-K., Kang, J., Yang, M., & Kang, B. (2020) · Korean Journal of Veterinary Research · doi:10.14405/kjvr.2020.60.1.19 · Cited by 10
“Further, theoretical side effects such as systemic infections, deleterious metabolic activities, excessive immune stimulation in susceptible individuals, gene transfer, and minor gastrointestinal symptoms have been reported [30].”
BackgroundMicrobiological quality of probiotic products
Zavišić, G., Ristić, S., Petković, B., Živkov-Šaponja, D., Jojić, N., & Janković, D. (2023) · Arhiv za farmaciju · doi:10.5937/arhfarm73-42160 · Cited by 9
Shanmukha, K. D., Pasupuleti, V., Yadav, K., Baviskar, S. M., Pradhan, M., Vora, L. K., & Khatri, D. K. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10796-9 · Cited by 9
“Patients administered with probiotics reported bacteremia associated with Lactobacillus species predominantly by Lactobacillus rhamnosis followed by L. acidophilus and L. casei [56].”
InfluentialRaudenská, M., Bugajová, M., Kalfeřt, D., Plzák, J., Šubrt, A., Tesařová, P., & Masařík, M. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189216 · Cited by 9
Fei, Y. Y., Steen, J. P., Tutt, E., Ng, J. Y., & Dobbins, M. (2023) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2023.102272 · Cited by 9
Next-Generation Probiotics Their Molecular Taxonomy and Health Benefits
Khan, S. T., & Malik, A. R. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-24903-8_16 · Cited by 9
Prebiotics, Probiotics, and Synbiotics: A Bifidobacterial View
Morelli, L., Callegari, M. L., & Patrone, V. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805060-6.00017-x · Cited by 9
Savytska, M., Kyriienko, D., Zaychenko, G. V., Ostapchenko, D., Falalyeyeva, T. M., & Kobyliak, N. M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1276642 · Cited by 9
“Signi fi cance was stated at р <0,05. their use to prevent, mitigate or treat speci fi c diseases (30).”
BackgroundAntibiotic Resistance Gene Expression in Veterinary Probiotics: Two Sides of the Coin
Kerek, Á., Román, I. L., Szabó, Á., Pézsa, N. P., & Jerzsele, Á. (2025) · Veterinary Sciences · doi:10.3390/vetsci12030217 · Cited by 9
“Despite their popularity, only a limited number of studies have provided strong clinical evidence for the health benefits of probiotics, highlighting the need for further investigation into their safety and efficacy [69,70].”
Kim, H. J., Kwon, M. Y., Song, S., Cheon, S. W., & Kim, H. J. (2025) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-025-04598-y · Cited by 9
“LAB strains, including commonly consumed pro-biotics such as Lactiplantibacillus plantarum and Levilac-tobacillus brevis , have been implicated in bacteremia and sepsis, particularly among immunocompromised individuals (Doron and Snydman 2015; Fanglei et al. 2020; Jeon et al. 2022 ).”
The Role of Probiotics and Their Postbiotic Metabolites in Post-COVID-19 Syndrome
Jach, M. E., Sajnaga, E., Bumbul, M., Serefko, A., Borowicz, K. K., Golczyk, H., Kieliszek, M., & Wiater, A. (2025) · Molecules · doi:10.3390/molecules30204130 · Cited by 9
“Lactic acid bacteria (LAB) (e.g., Lactobacillus s.l., Lactococcus , Enterococcus , and Streptococcus ), Bifidobacterium , and Bacillus species as well as Saccharomyces boulardii yeasts are considered to be the best studied [165,166].”
Bacterial extracellular vesicles as next-generation postbiotic for inflammatory bowel disease
Yu, Z., He, Y., Zhang, W., & Xie, J. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108637 · Cited by 9
Scope of Microbial Feed Additives in Ruminant Nutrition
Varada, V. V., & Kumar, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-0794-2_2 · Cited by 9
Thomas, R., Aldous, J., Forsyth, R., Chater, A., & Williams, M. (2021) · Infectious Diseases Diagnosis & Treatment · doi:10.29011/2577-1515.100182 · Cited by 9
“Some studies have shown a microbial-neuroendocrine relationship between certain dysbiotic flora species and the resultant adverse change in hormones and neurotransmitters such as acetylcholine and Gamma-Amino Butyrate (GABA), serotonin and dopamine and that administration of lactobacillus probiotics helped reverse the…”
BackgroundChan, W.-N., Ho, D., Huang, Y., Lin, J.-H., Liu, Y.-L., Chen, M.-C., & Chen, C.-S. (2023) · Transplantation Proceedings · doi:10.1016/j.transproceed.2023.08.011 · Cited by 9
Probiotic oral immunotherapy for egg and milk allergy induces sustained unresponsiveness
Lloyd, M., Loke, P., Nguyen, K., Pitkin, S., Ashley, S., Cantlay, A., Burns, J., Brown, H., Orsini, F., Tang, M. L. K., et al. (2025) · Pediatric Allergy and Immunology · doi:10.1111/pai.70222 · Cited by 9
Hassan, A. A.-M., & Elenany, Y. E. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10107-0 · Cited by 9
“Among the known probiotic microorganisms, species of lactic acid bacteria (LAB) (such as Lactococcus , Lactobacillus , Streptococcus , and Enterococcus ) and Bifido-bacterium have a long history of safe use [18].”
BackgroundComprehensive Metagenomic Analysis of Veterinary Probiotics in Broiler Chickens
Kerek, Á., Román, I. L., Szabó, Á., Papp, M., Bányai, K., Kardos, G., Kaszab, E., Bali, K., Makrai, L., & Jerzsele, Á. (2024) · Animals · doi:10.3390/ani14131927 · Cited by 8
“However, Enterococcus species, which harbor numerous ARGs, may not be the most suitable probiotic strains due to their potential for resistance gene transfer [41–43] and the fact that their health benefits have been clinically demonstrated in a limited number of cases [44,45].”
BackgroundAshique, S., Paul, D., Debnath, B., Chellappan, D. K., Das, J., Bhui, U., Ramzan, M., Sharma, N., Kumar, B., Sridhar, S. B., et al. (2025) · Nutritional Neuroscience · doi:10.1080/1028415x.2025.2560658 · Cited by 8
“Probiotics/psychobiotics are generally well tolerated, with adverse events typically limited to transient GI symptoms; however, safety outcomes are inconsistently reported, and rare serious complications have been described [150].”
Medical Therapies for Diarrhea-Predominant Irritable Bowel Syndrome
Sayuk, G. S. (2021) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2021.04.003 · Cited by 8
Clostridioides difficile infection in the allogeneic hematopoietic cell transplant recipient
Porto, D. L., Mularoni, A., Castagnola, E., & Saffioti, C. (2023) · Transplant Infectious Disease · doi:10.1111/tid.14159 · Cited by 8
The Gut–Brain Axis in Obesity: Mechanisms, Development, and Therapeutic Perspectives
Arellano-García, L., Portillo, M. P., Hadjihambi, A., Martinez, J. A., & Milton‐Laskibar, I. (2026) · Current Nutrition Reports · doi:10.1007/s13668-026-00732-w · Cited by 9
“Although probiotics have been proven effective for the management of obesity, the administration of viable bacteria may pose risks, such as systemic infections, deleterious metabolic activities, excessive immune stimulation or gene transfer in vulnerable individuals [ 168].”
Dong, Y., Zhang, Y., Xu, F., & Zou, K. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107100 · Cited by 8
Gut microbiome and rheumatoid arthritis: Revisiting the gut-joint axis
Kapoor, B., & Gulati, M. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115503 · Cited by 8
Overcoming Candida biofilm resistance: targeting persister cells with probiotic-derived metabolites
Debta, P., Sahu, B. K., Patra, S. K., Debta, F. M., Mishra, E., & Panda, S. K. (2026) · Frontiers in Antibiotics · doi:10.3389/frabi.2026.1767028 · Cited by 8
Kowalik, K., Kulig, K., Karnas, E., Woźnicka, O., Zuba‐Surma, E. K., Pyza, E., Rąpała‐Kozik, M., & Karkowska‐Kuleta, J. (2024) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2024.49 · Cited by 8
Probiotics and Prebiotics for the Treatment of Irritable Bowel Syndrome—A Narrative Review
Lopes, C. M., Monteiro, C. S. D. J., Duarte, A. P., & dos Santos, J. L. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216337 · Cited by 8
“There is some evidence that these may be beneficial in controlling the overall symptoms of IBS, with some products containing Lactobacillus having been shown to have a positive effect [75–77].”
BackgroundBaheti, R., Deshkar, S. S., Jadhav, S., Mule, K., Jha, A., Giram, P. S., & Mahore, J. (2026) · Food Research International · doi:10.1016/j.foodres.2026.118598 · Cited by 8
Saha, J., & Goswami, R. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10807-9 · Cited by 9
“…gut health or treating IBD [227] has met with quite a few contrasting reports stating severe side effects including recurrent septicemia, bacteremia [228], fungemia [229] to fatal comorbidities in acute pancreatitis patients [227, 230] arguing upon the broader effectiveness of the practice [231].”
Probiotics, prebiotics, and synbiotics in animal and poultry nutrition
Alagawany, M. M., Hegazy, M. I., Farag, M. R., El-Shall, N. A., Sallam, S. M. A., & Dhama, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13510-1.00002-5 · Cited by 8
Ryan, J. J., & Patno, N. (2021) · PubMed Central · Cited by 8
Exploring the culinary and health significance of fermented foods: A comprehensive review
Gondaliya, S. M., Sheth, J., & Shah, S. (2024) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2024.21.3.1000 · Cited by 8
“While many fermented foods offer undeniable health benefits, some may also pose risks, particularly for individuals with specific dietary restrictions or sensitivities [22-24].”
Babic, M., Veljović, K., Popović, N., Golić, N., Radojkovic, D. P., & Stankovic, M. M. (2023) · Journal of Applied Microbiology · doi:10.1093/jambio/lxad257 · Cited by 8
Emokpae, I., Tobia, D. L., Stamm, S. D., Lundy, P., Weimer, D. S., & Beckler, M. D. (2024) · Cureus · doi:10.7759/cureus.64833 · Cited by 8
“Adverse effects, though uncommon, may include bacteremia and minor gastrointestinal (GI) symptoms such as abdominal cramping, nausea, and taste disturbance [12,13].”
BackgroundYu, H.-Y., Kwon, M., Lee, Y.-S., Lee, S., & Kim, S.-K. (2023) · Fermentation · doi:10.3390/fermentation9030228 · Cited by 8
Lee, S. Y., & Ra, C. H. (2023) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-023-0073-9 · Cited by 8
“LAB species (Lactococcus, Lactobacillus, Streptococcus, and Enterococcus) and Bifidobacterium are among the best- known probiotics [11,12].”
BackgroundKhairani, A. F., Pamela, Y., Oktavia, N., Achadiyani, A., Adipraja, M. Y., Zhafira, P. Y., Shalannandia, W. A., & Atik, N. (2022) · Veterinary World · doi:10.14202/vetworld.2022.789-796 · Cited by 8
“On the other hand, another study demonstrates that probiotics in yogurt led to several side effects in susceptible individuals such as systemic infection, deleterious metabolic activities, and excessive immune stimulation [8].”
Hilakivi-Clarke, L. A., Verma, V., McDermott, M., Koak, P., & Andrade, F. D. O. (2022) · Frontiers in Microbiomes · doi:10.3389/frmbi.2022.1049688 · Cited by 7
“It is also concerning that commercial probiotics have been linked to bacteremia (Doron and Snydman, 2015; Lu et al., 2021), and that some probiotics have been shown to initiate cancer in an organoid culture (Pleguezuelos-Manzano et al.”
BackgroundArellano-García, L., Portillo, M. P., Martínez, J. A., Krisa, S., & Milton‐Laskibar, I. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.109982 · Cited by 7
Onofrei, M. I., Ghiciuc, C. M., Luca, C. M., Postolache, P. A., Sapaniuc, C., Enache-Leonte, G., & Roşu, F. M. (2023) · Medicina · doi:10.3390/medicina59030478 · Cited by 7
Probiotics for Trauma Patients: Should We Be Taking a Precautionary Approach?
Vitko, H. A., Sekula, L. K., & Schreiber, M. A. (2016) · Journal of Trauma Nursing · doi:10.1097/jtn.0000000000000263 · Cited by 7
Matera, M., Biagioli, V., Illiceto, M. T., Palazzi, C. M., Cavecchia, I., Manzi, A., Lugli, S., Pennazzi, L., Meocci, M., Pedaci, F. A., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1726630 · Cited by 7
Probiotics for primary prevention of Clostridioides difficile infection: revisiting the evidence
Fajnzylber, J. M., Patterson, W. M., & Deshpande, A. (2023) · Current Medical Research and Opinion · doi:10.1080/03007995.2023.2205333 · Cited by 7
Probiotics supplements for the prevention of atopic dermatitis in children: an umbrella review
Zhong, L., Su, J., Zhou, X., & Wan, H. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1587348 · Cited by 7
Horill, S., Zhou, X., & Jin, W. (2025) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2025.111801 · Cited by 7
Mitigation of Foodborne Illnesses by Probiotics
Ryan, V., & Bhunia, A. K. (2017) · Springer eBooks · doi:10.1007/978-3-319-56836-2_21 · Cited by 7
Microbial-based cleaning products as a potential risk to human health: A review
Maestra, S. L., D’Agostini, F., Geretto, M., & Micale, R. T. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.09.013 · Cited by 7
ProbResist: a database for drug-resistant probiotic bacteria
Dou, W., Abdalla, H. B., Chen, X., Sun, C., Chen, X., Tian, Q., Wang, J., Zhou, W. J., Chi, W., Zhou, X., et al. (2022) · Database · doi:10.1093/database/baac064 · Cited by 7
Nwinyi, O. C., & Umane, P. O. (2019) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/331/1/012057 · Cited by 7
“Also Commercial Bambara nut collected from South- West Nigeria by [22] revealed to possess moisture content of (%) 7 Protein (%) 18 Fat (%) 6, Ash (%) 4 , Crude fiber (%) 4 and Carbohydrate 60%.”
BackgroundPets as a Novel Microbiome-Based Therapy
Garcia, M. C. S., Schorr, A. R., Arnold, W., Fei, N., & Gilbert, J. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-30734-9_11 · Cited by 7
Healthcare associated diarrhea, not Clostridioides difficile
Turner, N., Saullo, J. L., & Polage, C. R. (2020) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000653 · Cited by 7
“It is also important to consider the possibility of adverse effects with probiotics, particularly in patients with compromised immune systems, as reports of systemic infection with probiotic therapies, including Saccharomyces, Streptococcus and Lactobacillus, have been reported [66].”
BackgroundProbiotics Safety Aspect of Functional Foods
Oba, Ş., Yıldırım, T., & Karataş, Ş. M. (2022) · Journal of Culinary Science & Technology · doi:10.1080/15428052.2022.2135156 · Cited by 7
Kunishima, H., Ichiki, K., Ohge, H., Sakamoto, F., Sato, Y., Suzuki, H., Nakamura, A., Fujimura, S., Matsumoto, K., Mikamo, H., et al. (2024) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2024.03.018 · Cited by 7
Therapeutic dietary approach to children with autistic spectrum disorder
Torres, F. C. I., Medina, A. C. D. G., Toribio, S. L. G., Guevara, K. K. J., Risco, K. B. L., & Huamán-Saavedra, J. J. (2022) · Revista de la Facultad de Medicina Humana · doi:10.25176/rfmh.v22i4.4729 · Cited by 7
Dysbiosis promotes recurrence of adenomatous polyps in the distal colorectum
Yin, L., Qi, P., Hu, Y., Fu, X., He, R.-S., Wang, M., Deng, Y.-J., Xiong, S.-Y., Yu, Q., Hu, J., et al. (2024) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v16.i8.3600 · Cited by 7
Maione, A., Matuozzo, M., Imparato, M., DˈAmbrosio, C., de Alteriis, E., Guida, M., Scaloni, A., & Galdiero, E. (2026) · Nutrients · doi:10.3390/nu18060912 · Cited by 7
“In such individuals, probiotic therapy may worsen inflammatory responses and convert probiotic bacteria into harmful microorganisms [16,17].”
Probiotics for the postoperative management of term neonates after gastrointestinal surgery
Trivedi, A., Teo, E., & Walker, K. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012265.pub2 · Cited by 7
Lim, A., Baek, J., Seo, M., Kim, K.-Y., Kim, S., Kwak, W., Lee, J. H., Kwak, J., Yoon, W.-J., Kim, W., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-16102-5 · Cited by 7
Đanić, M., Pavlović, N., Ostojić, T., Marković, N., Stanimirov, B., Lazarević, S., & Mikov, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1601876 · Cited by 7
“Theoretical concerns include systemic infections, excessive immune stimulation, and horizontal gene transfer (50, 51).”
Wang, J., Ma, T., Xie, Y., Li, K., Luo, C., Teng, C., Yi, B., Chen, L., & Zhang, H. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.03.025 · Cited by 7
“Therefore, testing conducted with in vitro models are gaining more attention for their convenience and efficiency [13].”
Choi, Y. H., Kim, B. S., & Kang, S. (2023) · Food Science of Animal Resources · doi:10.5851/kosfa.2023.e43 · Cited by 7
Bacillus clausii Bacteremia After Probiotic Usage in a Pediatric Patient
Erbaş, İ. C., Nişancı, B., Gür, B., Makay, B. B., İnce, T., & Belet, N. (2023) · Clinical Pediatrics · doi:10.1177/00099228231207306 · Cited by 7
Ho, Y.-H., Huang, Y.-T., Lu, Y.-C., Lee, S.-Y., Tsai, M.-F., Hung, S.-P., & Hsu, T.-Y. (2017) · The Journal of nutrition, health and aging · doi:10.1007/s12603-016-0818-7 · Cited by 6
Messina, B. M., Polizzi, A., Panuzzo, C., Belmonte, A., Angjelova, A., Fuochi, V., Annunziata, M., & Isola, G. (2025) · Life · doi:10.3390/life15121862 · Cited by 6
“Current recommendations suggest that probiotics may be considered only in patients with stable immune function, in consultation with the treating hematologist, and using well-characterized strains with documented safety in immunocompromised populations [91].”
Wang, X., Wei, Z., Xiang, Q., Tang, L., & Xie, W. (2025) · Microorganisms · doi:10.3390/microorganisms13081894 · Cited by 6
“While probiotics are generally regarded as safe, theoretical risks have been identified, including the potential for systemic infections, harmful metabolic activities, excessive immune responses in vulnerable individuals, gene transfer, and gastrointestinal side effects [128].”
Advances in Probiotics for Health and Nutrition
Zambare, V., Din, M. F. M., Gupta, P., & Prajapati, B. G. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.104299 · Cited by 6
Lertcanawanichakul, M., Bhoopong, P., Madoromae, H., & Sahabuddeen, T. (2026) · Pharmacoepidemiology · doi:10.3390/pharma5010003 · Cited by 6
“The risk of probiotic-associated sepsis is extremely low but warrants caution in severely immunocompromised pediatric patients [21,22].”
Carrega, G., Ricciardi, B., Bartolacci, V., Brenci, S., Izzo, M., Morelli, P., Tigano, S., & Riccio, G. (2023) · PubMed Central · doi:10.53854/liim-3103-13 · Cited by 6
“A possible role of Lactobacillus in the development of invasive infections should be considered in patients who regularly take probiotics [29].”
BackgroundRen, T., Yin, Y., Zhou, X., Chen, L.-W., Shen, Y., Feng, H., Zhou, C., Xu, Y., & Ling, Y. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120143 · Cited by 6
Butler, C., Owen-Jones, E., Lau, M., Gillespie, D., Lown, M. T., Calder, P. C., Stanton, H., Wootton, M., Herrera, V. C., Bayer, A. J., et al. (2021) · Efficacy and Mechanism Evaluation · doi:10.3310/eme08070 · Cited by 6
Unveiling the Therapeutic Potential of Probiotics in Sepsis: A Review
Wang, Z., Huang, J., & Zhao, P. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70364 · Cited by 6
Assessment of gut microbiota in the elderly with sarcopenic obesity: a case-control study
Hosseini, F., Behrouzi, A., Shafaie, E., Sharifi, F., & Ejtahed, H. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01584-x · Cited by 6
“For instance, certain Bifidobacterium strains, such as B. longum and B. bifidum , offer probiotic benefits like reducing inflammation, while others may have little to no effect [29 –33].”
Kumari, M., & Kokkiligadda, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822909-5.00004-6 · Cited by 6
Prebiotics and Probiotics Food
Sankarganesh, P., Adeyeye, S. A. O., Chakka, A. K., & Babu, A. S. (2024) · Wiley eBooks · doi:10.1002/9781394237623.ch16 · Cited by 6
Sarid, L., & Ankri, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.841586 · Cited by 6
“Regarding safety, probiotics are generally considered harmless for immunocompetent individuals but sepsis in immunocompromised individuals or critically ill patients has been reported (Doron and Snydman, 2015).”
BackgroundAlexander, L. M., Khalid, S., Gallego-López, G. M., Astmann, T. J., Oh, J., Heggen, M., Huss, P., Fisher, R., Mukherjee, A., Raman, S., et al. (2024) · Applied and Environmental Microbiology · doi:10.1128/aem.00312-24 · Cited by 6
“For some applications of probiotics or effector molecule delivery by bacteria, it may be ideal for the delivery vehicle to lack immunomodulatory effects that may be detrimental in certain disease states, such as in patients with severely compromised immune systems (78, 79).”
Postbiotics in Functional Foods: Production, Delivery, Preservation, and Regulation
Ali-Haneef, N., Mohite, A. R., Muruganantham, P., Salim, A. A., Chinannai, K. S., John, A., & Madar, I. H. (2026) · Foods · doi:10.3390/foods15142434 · Cited by 6
“Safety concerns have also been reported in vulnerable populations, including preterm infants, immunocompromised individuals, and patients with impaired gut barrier function, further limiting the scope of universal application [5].”
Das, D., Rath, C. C., Mohanty, N., & Panda, S. H. (2021) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2021.v14i12.43204 · Cited by 6
Extracellular vesicles in dairy cattle: research progress and prospects for practical applications
Wang, N., Zhang, B., Loor, J. J., Li, C., & Zhou, X. (2025) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-025-01242-5 · Cited by 6
“Manipulating the microbiota of dairy cattle through EVs may reduce the side effects associated with direct-fed microbials, such as overstimulation of the immune response, harmful metabolic reactions, and drug incompatibility [155–157].”
Kumar, S., Bansal, K., & Sethi, S. K. (2023) · Ecological Genetics and Genomics · doi:10.1016/j.egg.2023.100205 · Cited by 6
Application of Probiotics and Postbiotics in Neurological Disorders
Mohammadpour, D., Asadollahi, A., Ozma, M. A., Mehramuz, B., Ganbarov, K., & Kafil, H. S. (2025) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010336767250128072101 · Cited by 6
Sliti, A., Kim, R.-H., Lee, D., & Shin, J.-H. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107405 · Cited by 5
Mechanistic insights into postbiotics as therapeutic agents in type 2 diabetes management
Ebadpour, N., Faraji, N., Abavisani, M., Karav, S., & Sahebkar, A. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04456-6 · Cited by 5
“Individuals who are immunocompromised, have just undergone surgery, suffer from cardiac or gastrointestinal illnesses, are pregnant, or are children are also included within this group, along with the potential for adverse reactions (Doron and Snydman 2015; Sanders et al. 2016; Pugin et al. 2017).”
The Hygienic Significance of Microbiota and Probiotics for Human Wellbeing
Todorov, S. D., Tagg, J. R., Algburi, A., Tiwari, S. K., Popov, I. V., Weeks, R. M., Mitrokhin, O. V., Kudryashov, I. A., Александрович, К. Д., & Chikindas, M. L. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10419-9 · Cited by 5
“Side effects occur rarely in a very small number of case reports (one in one million) using experimental models [241].”
Expert Opinion on the Use of Probiotics in Recurrent Pregnancy Loss
Patki, A. S., Kunjimoideen, K., Sawankar, S., Tyagi, R., Hegde, V., & Budi, J. (2025) · Cureus · doi:10.7759/cureus.81056 · Cited by 5
Kralj, S., Zeman, K., Mikuš, M., Karačić, A., Pršo, A.-M. L., Ćorić, M., & Renko, I. (2026) · Trials · doi:10.1186/s13063-025-09405-5 · Cited by 5
“Probiotics are generally regarded as safe, with no to minimal adverse health effects [29–31].”
Liu, W., Lü, N., Zhou, X., Li, Y., Xie, Y., Zheng, L., Zhu, W., Xiao, Q., Yang, N., Zuo, K., et al. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/4144321 · Cited by 5
“However, four types of adverse reactions related to probiotics should be considered, including symptoms that may be attributed to systemic infections, deleterious metabolic activities, excessive immune stimulation, and gastrointestinal side effects [60], which will be collected as possible adverse events during the st…”
Background
Metadata
- Authors
- Doron, S., & Snydman, D. R.
- Affiliations
- Tufts Medical Center (US)
- Corresponding author
- Doron, Shira
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-28
- Volume
- 60
- Issue
- suppl_2
- Pages
- S129-S134
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC4490230
- OpenAlex
- W2027617880
- Cited by
- 942
- References
- 91
- Citations by year
- 2026: 89 · 2025: 105 · 2024: 112 · 2023: 105 · 2022: 99 · 2021: 100 · 2020: 135 · 2019: 85 · 2018: 55 · 2017: 32 · 2016: 18 · 2015: 7
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k23at003391-03)
- National Center for Complementary and Integrative Health (K23 AT-003391, 5K23 AT003391-03)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, probiotic safety, adverse events, systemic infection, immunostimulation, gene transfer, gastrointestinal adverse effects, risk assessment
- MeSH terms
- Clinical Trials as Topic, Humans, Lactobacillus, Risk, Saccharomyces, United States, Fungemia, Sepsis, Probiotics, Gene Transfer, Horizontal, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.